New cancer clinical trial: Open-Labeled Phase 1 Study for Apatinib Plus Nivolumab in Patients With Unresectable or Metastatic Cancer

Published on: January 10, 2018 at 12:00PM
Condition:   Cancer
Interventions:   Drug: Apatinib;   Drug: Nivolumab
Sponsor:   LSK BioPartners Inc.
Recruiting
http://ift.tt/2mqc5k3